Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
about
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@en
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@nl
type
label
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@en
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@nl
prefLabel
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@en
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@nl
P2093
P2860
P1433
P1476
Subcutaneous Interferon-β1a Do ...... nd Post-Marketing Surveillance
@en
P2093
Alan Gillett
Brooke Hayward
Julie Aldridge
Meritxell Sabidó
Saritha Venkatesh
P2860
P2888
P304
P356
10.1007/S12325-018-0790-1
P407
P577
2018-11-01T00:00:00Z